Treating osteoporosis: An overview of the evidence for the bisphosphonates

Research output: Contribution to journalComment / DebateOtherpeer-review


The newer, potent bisphosphanates have demonstrated the most significant and consistent reduction in the risk of multiple fractures across trials. The results of large, long-term trials examining the anti-fracture efficacy of hormone replacement therapy are awaited. Based on the evidence to date the bisphosphonates are the treatments of choice for postmenopausal osteoporotic women with fracture, with HRT being the preferred treatment for early postmenopausal women with osteoporosis.

Original languageEnglish
Number of pages1
JournalMedicine Today
Issue number7
Publication statusPublished - 24 Jul 2001
Externally publishedYes

Cite this